Lab news | 2010

30/11/2010

Khuloud wins Royal Society Research Project Award

Dr Khuloud Al-Jamal has won a competitive Royal Society Research Project award for a collaboration between the Nanomedicine Lab, the University of Barcelona and Oxford University.

30/10/2010

PhD graduate – Ms. Hanene Ali-Boucetta

Dr. Hanene Ali-Boucetta obtained her PhD thesis titled ’The development of carbon nanotubes as cancer therapeutics: from pharmacokinetics and toxicology to therapy’. She rejoined the Nanomedicine lab as a Research and Teaching Fellow working on the engineering of carbon nanotubes as multimodal modalities for cancer therapy.

 

30/10/2010

Neus joins the Nanomedicine Lab as the Andalucian Initiative for Advanced Therapies Postdoctoral Fellow

Dr Neus Lozano Valdes was awarded a Postdoctoral Fellowship by the Regional Government of Andalucia (Junta de Andalucia) supported by the Andalucian Intiative for Advanced Therapies for 2 years.

05/10/2010

Kostas delivers the 67th GMSI Open Seminar at the University of Tokyo

Professor Kostarelos was the 67th open seminar at the Global Center of Excellence for Mechanical Systems Innovation (GMSI) at the University of Tokyo.

06/09/2010

Kostas delivers the 55th iCeMS Seminar at the Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University

Professor Kostarelos gave the 55th iCeMS Seminar at the Institute for Integrated Cell-Material Sciences (iCeMS) of Kyoto University with the tilte: Engineering the Cell Biology and Cytotoxicity of Nanomaterials: The Case of Carbon Nanotubes. In the seminar he showed specific examples of engineering carbon nanotube material to achieve control over their cell biology (binding, internalisation and intracellular trafficking) on interaction with cell cultures and the correlation with their cytotoxic impact and ensuing cell viability will be shown. Such engineering exercises are considered essential in the development of CNT for biomedical and eventually clinical use.

 

01/07/2010

Kostas is awarded Japanese Society for the Promotion of Science (JSPS) Invitation Professorial Fellowship

Professor Kostas Kostarelos was awarded the highly competitive JSPS Fellowship. He was hosted by Dr.M.Yudasaka and Prof.S.Iijima at the Nanotube Research Center of the National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan from July-November 2010.

21/06/2010

Khuloud Chairs Sessions and Speaks at the NANOTECH 2010 Conference and Expo

Dr Khuloud Al-Jamal chaired the special symposium on Materials of Drug and Gene Delivery at the Nanotech Conference and Expo 2010 at the Nanotech Conference and Expo 2010 in Anaheim (CA, USA). She was joined by Dr Wafa Al-Jamal, Mr.A.Nunes and Mr.B.Tian.

 

30/05/2010

Ms. Hanene Ali-Boucetta is awarded a Maplethorpe Fellowship

Our PhD student Ms. Hanene Ali-Boucetta that recently submitted her thesis, was awarded a  CW Maplethorpe Postdoctoral Fellowship for Pharmaceutical Education and Research. The Fellowships have been established under the Will of the late Mr Cyril W Maplethorpe for the promotion of pharmaceutical education and research at the University College London School of Pharmacy

28/05/2010

Kostas speaks at the GENNESYS 2010 International Congress in Barcelona

Professor Kostarelos was one of the invited speakers at the GENNESYS 2010 International Congress on nanotechnology and research infrastructures in Barcelona, Spain held under the auspices of the Ministry of Research and Innovation of Spain during the Spanish EU-Presidency. The GENNESYS project has provided a vision for future strategies in nanoscience and nanotechnology under the auspices of the Max-Planck Institute, Stuttgart.

 

30/04/2010

Best poster award to Acelya

Ms. Acelya Yilmazer, one of our PhD students, won the best poster award with her ‘Artificial Envelopment of Adenovirus and its Effect on Viral Liver Tropism’ poster during the School of Pharmacy Research Day.

30/03/2010

PhD graduate – Ms. Jennifer Podesta

Dr Jennifer Podesta obtained her PhD with the thesis titled: ‘Engineering liposome-siRNA vectors for anti-angiogenic tumour therapeutics by gene silencing’.